Close
Back to ITOS Stock Lookup

(ITOS) – FDA

May 11, 2022 06:45 AM Arcus (ACUS), iTeos Therapeutics (ITOS) Sink as Roche's anti-TIGIT Drug Fails in Phase 3 Trial
Dec 9, 2021 04:02 PM iTeos Therapeutics (ITOS) Announces New Data for its Anti-TIGIT Antibody, EOS-448, at the American Society of Hematology Annual Meeting and TIGIT Therapies Digital Summit 2021
Jun 14, 2021 07:06 AM

Back to ITOS Stock Lookup